Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × Bortezomib × Clear all

NCT00066352 2015-07-23

Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter

Phase 2 Completed

Urinary Bladder Neoplasms

NCT00072150 2013-06-05

Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma

Phase 2 Completed

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms